Patients with Duffy null status are more likely to experience misdiagnoses, unnecessary medical tests, and increased health ...
Kashiv BioSciences commercially launched Pexegra, a biosimilar referencing Neulasta, and Filra, a biosimilar referencing ...
A monocyte mitochondrial superoxide cutoff accurately stratified short-term survival risk in hepatocellular carcinoma.
Immuneering Corporation - Special CallCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO & DirectorConference Call ...
The regulatory approval of the oral estrogen receptor antagonist is for patients whose cancer has an ESR1 mutation and has ...
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company’s CEO ...
The Slovak Academy of Sciences (SAV) published a long-awaited report on the composition of Covid-19 vaccines, a renowned ...
A research team from Umeå University, Sweden, in collaboration with Ghent University, Belgium, has made a groundbreaking discovery about how the body's first immune defense, neutrophils, orchestrate ...
C4 Therapeutics' zinc finger protein-1 and 3 (IKZF1/3) degrader cemsidomide has demonstrated an overall response rate (ORR) ...
MedPage Today on MSN
Ulcerative Colitis: Next Target for CAR T-Cell Therapy?
The range of autoimmune diseases treatable with chimeric antigen receptor (CAR) T-cell therapy could be much broader than ...
During a live event, Raajit K. Rampal, MD, PhD, discussed ropeginterferon's potential to reduce JAK2 allele burden in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback